Semiparametric inference for proportional mean residual life models with clustered survival data

Mean residual life regression models attract considerable attention in the recent study of survival data analysis. However, all the existing works focus on independent survival data incapable of applying to the analysis of clustered data, which are frequently encountered in biomedical studies. This...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Huang, Rui
مؤلفون آخرون: Xiang Liming
التنسيق: Thesis-Doctor of Philosophy
اللغة:English
منشور في: Nanyang Technological University 2020
الموضوعات:
الوصول للمادة أونلاين:https://hdl.handle.net/10356/143100
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
المؤسسة: Nanyang Technological University
اللغة: English
الوصف
الملخص:Mean residual life regression models attract considerable attention in the recent study of survival data analysis. However, all the existing works focus on independent survival data incapable of applying to the analysis of clustered data, which are frequently encountered in biomedical studies. This thesis aims to develop novel methodologies based on mean residual life models to account for the dependency caused by the clustered structure in data. The first method is proposed using the hierarchical quasi-likelihood in the construction of the quasi-likelihood function. It can avoid the estimation challenges and be simply implemented via an iterative algorithm. An explicit distributional assumption is still needed while it is hard to be verified in the practice. A more flexible model framework is further developed by the penalized quasi-likelihood method, leading to a broader range of applications for the proposed frailty model and the estimator of regression parameters with asymptotic properties. Extensive simulation studies have been carried out and results show promising finite sample performance of both proposed methodologies. The utility of proposed models is illustrated by their applications to the data from a multi-center trial study of breast cancer.